Medical and surgical treatment options for pulmonary hypertension

American Journal of the Medical Sciences

Volumn 315, Issue 3, 1998, Pages 179-184

  Gaine, Sean P ^a   Rubin, Lewis J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Epoprostenol; Lung transplantation; Pulmonary hypertension

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; PROSTACYCLIN; VASODILATOR AGENT;

CONFERENCE PAPER; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; HEART CATHETERIZATION; HUMAN; KINESIOTHERAPY; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; PROGNOSIS; PULMONARY HYPERTENSION; QUALITY OF LIFE; SURVIVAL RATE;

EID: 0031940987     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199803000-00006     Document Type: Conference Paper

References (50)

1. Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982;306:557-64.
2. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992;327:76-81.
3. Rubin LJ, Mendoza J, Hood M, et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial. Ann Intern Med. 1990;112:485-91.
4. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with con ventional therapy for primary pulmonary hypertension: the Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;334:296-302.
5. Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med. 1994;121:409-15.
6. Rich S. Medical treatment of primary pulmonary hypertension: a bridge to transplantation? Am J Cardiol. 1995;75:63A-66A.
7. Conte JV, Gaine SP, Orens JB, Fiocco M, Harris T, Rubin LJ. Continuous intravenous prostacyclin as a bridge to lung transplantation. J Heart Lung Transplant. 1998 (in press).
8. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336:111-7.
9. Rich S, Levy PS. Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension. Am J Med. 1984;76:573-8.
10. Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J. 1986;55:449-58.
11. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med. 1987;107:216-23.
12. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115:343-9.
13. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation. 1984;70:580-7.
14. Glanville AR, Burke CM, Theodore J, Robin ED. Primary pulmonary hypertension: length of survival in patients referred for heart-lung transplantation. Chest. 1987;91:675-81.
15. Braman SS, Eby E, Kuhn C, Rounds S. Primary pulmonary hypertension in the elderly. Arch Intern Med. 1991;151:2433-8.
16. Bjornsson J, Edwards WD. Primary pulmonary hypertension: a histopathologic study of 80 cases,. Mayo Clin Proc. 1985;60:16-25.
17. Rich S, Brundage BH. High dose calcium channel blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary artery pressure and regression of right ventricular hypertrophy. Circulation. 1987;76:135-41.
18. Uren NG, Ludman PF, Crake T, Oakley CM. Response of the pulmonary circulation to acetylcholine, calcitonin generelated peptide, substance P and oral nicardipine in patients with primary pulmonary hypertension. J Am Coll Cardiol. 1992;19:835-41.
19. Jones DK, Higenbottam TW, Wallwork J. Treatment of primary pulmonary hypertension with intravenous epoprostenol (prostacyclin). Br Heart J. 1987;57:270-8.
20. Higenbottam TW, Wells F, Wheeldon D, Wallwork J. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet. 1984;1:1046-7.
21. Shapiro SM, Oudiz RJ, Cao T, Romano MA, et. al. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoerostenol infusion. J Am Coll Cardiol. 1997;30:343-9.
22. Hardy JD, Webb WR, Dalton ML, Walker GR. Lung homotransplantation in man: report of the initial case. JAMA. 1963;186:1065-74.
23. Cooley DA, Bloodwell RD, Hallman GL, Nora JJ, Harrison GM, Leachman RD. Organ transplantation for advanced cardiopulmonary disease. Ann Thorac Surg. 1969;8:30-46.
24. Borel JF, Feuer C, Magnee C, Stahelin H. Effects of the new antilymphocytic peptide cyclosporin A in animals. Immunology. 1977;32:1017-25.
25. Calne RY, White DJ, Thiru S, et al. Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet. 1978;2:1323-7.
26. Group TLT. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med. 1986;314:1140-5.
27. Pasque MK, Cooper JD, Kaiser LR, Haydock DA, Triantafillou AN, Trulock E. Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg. 1990;49:785-91.
28. Moser KM, Daily PO, Peterson K, et al. Thromboendarterectomy for chronic, major vessel thromboembolic pulmonary hypertension: immediate and long-term results in 42 patients. Ann Intern Med. 1987;107:560-5.
29. Dittrich HC, Nicod PH, Chow LC, Chappuis FP, Moser KM, Peterson KL. Early changes of heart geometry after pulmonary thromboendarterectomy. J Am Coll Cardiol. 1988;11:937-43.
30. Levine SM, Gibbons WJ, Bryan CL, et al. Single lung transplantation for primary pulmonary hypertension. Chest. 1990;98:1107-15.
31. Starnes VA, Stinson EB, Oyer PE, et al. Single lung transplantation: a new therapeutic option for patients with pulmonary hypertension. Transplant Proc. 1991;23:1209-10.
32. Pasque MK, Kaiser LR, Dresler CM, Trulock E, Triantafillou AN, Cooper JD. Single lung transplantation for pulmonary hypertension. Technical aspects and immediate hemodynamic results. J Thorac Cardiovasc Surg. 1992;103:475-81.
33. Pasque MK, Trulock EP, Cooper JD, et al. Single lung transplantation for pulmonary hypertension. Single institution experience in 34 patients. Circulation. 1995;92:2252-8.
34. Ritchie M, Waggoner AD, Davila-Roman VG, Barzilai B, Trulock EP, Eisenberg PR. Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation. J Am Coll Cardiol. 1993;22:1170-4.
35. Kramer MR, Valantine HA, Marshall SE, Starnes VA, Theodore J. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. Am J Cardiol. 1994;73:494-500.
36. Fremes S, Patterson GA, Williams WG, et al. Single lung transplant and closure of patent ductus arteriosis for Eisenmenger's syndrome. J Thorac Cardiovasc Surg. 1990;100:1-5.
37. Lupinetti FM, Boiling SF, Bove EL, et al. Selective lung or heart-lung transplantation for pulmonary hypertension associated with congenital cardiac anomalies. Ann Thorac Surg. 1994;57:1545-8.
38. Orens JB, Becker FS, Lynch JP III, Christensen PJ, Deeb GM, Martinez FJ. Cardiopulmonary exercise testing following allogeneic lung transplantation for different underlying disease states. Chest. 1995;107:144-9.
39. Bando K, Keenan RJ, Paradis IL, et al. Impact of pulmonary hypertension on outcome after single-lung transplantation. Ann Thorac Surg. 1994;58:1336-42.
40. Levine SMJ, Erikinson SG, Bryan CL, et al. Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension. Chest. 1992;101:401-5.
41. Trulock EP. State of the art: lung transplantation. Am J Respir Crit Care Med. 1997;155:789-818.
42. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: fourteenth official report - 1997. J Heart Lung Transplant. 1997;16:691-712.
43. Division of Transplantation, Bureau of Health Resources Development. 1995 Annual Report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network-Transplant Data: 1988-1994. Rockville, MD: Health Resources and Services Administration, US Department of Health and Human Services, 1995.
44. Kshettry VR, Kroshus TJ, Savik K, Hertz MI, Bolman RM. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients. Chest. 1996;110:704-9.
45. UNOS. UNOS Update. 1995;11:33-6.
46. St. Louis International Lung Transplant Registry. Report. April 1996.
47. Ramsey SD, Patrick DL, Lewis S, Albert RK, Raghu G, Group at University of Washington Lung Transplant Study Group. Improvement in quality of life after lung transplantation: a preliminary study. J Heart Lung Transplant. 1995;14:870-7.
48. Gross C, Savik K, Bolman RM, Hertz MI. Long-term health status and quality of life outcomes of lung transplant recipients. Chest. 1995;108:1587-93.
49. Ramsey SD, Patrick DL, Albert RK, et al. The cost-effectiveness of lung transplantation: a pilot study. Chest. 1995;108:1594-1601.
50. Evans RW, Manninen DL, Dong FB. An economic analysis of heart-lung transplantation: costs, insurance coverage, and reimbursement. J Thorac Cardiovasc Surg. 1993;105:972-8.